Pembrolizumab (MK-3475) is a Humanized anti-PD-1 IgG4 Antibody for Cancer Research
Programmed death 1 (PD-1), also known as CD279, belongs to the CD28 superfamily. Firstly, PD-1 is an inhibitory receptor that is expressed on T cells, NK cells, B cells, monocytes,…